|
Market Closed -
Toronto S.E.
22:24:12 23/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 32.45 CAD | -1.96% |
|
+1.72% | +30.64% |
| 10-23 | Amgen's Growth Drivers, Pipeline Could Support Longer-Term Outlook, Oppenheimer Says | MT |
| 10-23 | Oppenheimer Adjusts Amgen Price Target to $480 From $450, Maintains Outperform Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMGEN INC. | Other Pharmaceuticals | -1.96% | +1.72% | +30.64% | - | - | 237B |
-
|
-
|
-
|
- Stock Market
- Stocks
- AMGN Stock
- AMGN Stock
- Charts Amgen Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
